Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.07B |
| 2 |
SPCX
SpaceX
SPCX
|
+$2.99B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.11B |
| 4 |
Microsoft
MSFT
|
+$584M |
| 5 |
Bloom Energy
BE
|
+$547M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.65B |
| 2 |
Marvell Technology
MRVL
|
+$1.16B |
| 3 |
Apple
AAPL
|
+$1.12B |
| 4 |
SNDK
Sandisk
SNDK
|
+$1.11B |
| 5 |
Micron Technology
MU
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.34% |
| 2 | Technology | 9.51% |
| 3 | Industrials | 7.53% |
| 4 | Financials | 5.78% |
| 5 | Healthcare | 5.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PURR
1926
Hyperliquid Strategies Inc
PURR
$2.5B
| $13.4M | ﹤0.01% |
1,705,218
+805,915
| +90% | +$5.96M |
|
1927
Regions Financial
RF
$24.5B
| $13.4M | ﹤0.01% |
443,435
-2,206,404
| -83% | -$61.9M |
|
1928
Pfizer
PFE
$158B
| $13.4M | ﹤0.01% |
556,133
+459,769
| +477% | +$12M |
|
1929
Darling Ingredients
DAR
$10.5B
| $13.4M | ﹤0.01% |
245,056
-2,639,156
| -92% | -$158M |
|
1930
PUT
SELLAS Life Sciences
SLS
$2.33B
| $13.4M | ﹤0.01% |
906,000
+280,000
| +45% | +$1.93M |
|
1931
NNN REIT
NNN
$8.02B
| $13.4M | ﹤0.01% |
287,362
-3,599
| -1% | -$161K |
|
1932
Weis Markets
WMK
$1.81B
| $13.3M | ﹤0.01% |
170,001
-22,653
| -12% | -$1.66M |
|
|
IVA
1933
Inventiva
IVA
$886M
| $13.3M | ﹤0.01% |
3,512,174
+524,561
| +18% | +$2.52M |
|
1934
CALL
Marriott International
MAR
$87.4B
| $13.3M | ﹤0.01% |
35,800
-60,700
| -63% | -$22.4M |
|
1935
Corcept Therapeutics
CORT
$12B
| $13.3M | ﹤0.01% |
152,567
-406,180
| -73% | -$24.5M |
|
1936
Twilio
TWLO
$37.3B
| $13.3M | ﹤0.01% |
64,265
-571,387
| -90% | -$101M |
|
1937
MDU Resources
MDU
$3.96B
| $13.3M | ﹤0.01% |
624,798
+290,833
| +87% | +$6.33M |
|
1938
Vornado Realty Trust
VNO
$6.5B
| $13.2M | ﹤0.01% |
336,992
-477,028
| -59% | -$15.4M |
|
1939
Louisiana-Pacific
LPX
$4.62B
| $13.2M | ﹤0.01% |
+167,832
| New | +$12.4M |
|
1940
Lexeo Therapeutics
LXEO
$348M
| $13.2M | ﹤0.01% |
2,833,622
+1,220,842
| +76% | +$6.6M |
|
1941
Compañía de Minas Buenaventura
BVN
$8.79B
| $13.2M | ﹤0.01% |
450,163
-103,086
| -19% | -$3.5M |
|
1942
CALL
State Street SPDR S&P Retail ETF
XRT
$395M
| $13.2M | ﹤0.01% |
150,000
-100,000
| -40% | -$8.42M |
|
|
1943
PUT
State Street SPDR S&P Retail ETF
XRT
$395M
| $13.2M | ﹤0.01% |
150,000
| – | – |
|
1944
Hexcel
HXL
$6.65B
| $13.1M | ﹤0.01% |
131,349
+81,801
| +165% | +$7.41M |
|
1945
AngloGold Ashanti
AU
$51.6B
| $13.1M | ﹤0.01% |
162,102
-28,304
| -15% | -$2.69M |
|
|
PTOR
1946
Praetorian Acquisition Corp
PTOR
$339M
| $13.1M | ﹤0.01% |
+1,320,000
| New | +$13M |
|
1947
Bright Horizons
BFAM
$3.28B
| $13.1M | ﹤0.01% |
184,789
-904,310
| -83% | -$65.4M |
|
1948
CALL
Boston Scientific
BSX
$62.8B
| $13.1M | ﹤0.01% |
306,800
-525,800
| -63% | -$28.6M |
|
1949
CALL
GlobalFoundries
GFS
$25.5B
| $13.1M | ﹤0.01% |
158,800
+6,100
| +4% | +$426K |
|
1950
Albemarle
ALB
$13.6B
| $13.1M | ﹤0.01% |
96,866
-404,101
| -81% | -$71.3M |
|
Similar funds
Millennium Management's Q2 2026 Portfolio in Review
As of Q2 2026, Millennium Management held 6,628 positions worth $276B, up 15% from $240B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management's Q2 2026 filing shows 986 new, 2,006 increased, 2,341 reduced and 833 closed positions. Its largest new stake was SpaceX: 17,604,863 shares worth $2.98B. The largest sale was State Street SPDR Portfolio S&P 500 ETF, an estimated $1.65B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, up from 54% a quarter earlier, followed by Technology and Industrials.
- Millennium Management's largest Q2 2026 buy was SpaceX: 17,604,863 shares worth $2.98B.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $3.07B increase.
- Millennium Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $1.16B.
- Millennium Management fully exited State Street SPDR Portfolio S&P 500 ETF in Q2 2026, selling an estimated $1.65B.
- Millennium Management's ten largest holdings make up 18% of its $276B portfolio in Q2 2026.
- Millennium Management opened 986 new positions and closed 833 in Q2 2026.
- Millennium Management's portfolio value rose 15% quarter-over-quarter to $276B.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.